Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 104


The ECM protein LTBP-2 is a suppressor of esophageal squamous cell carcinoma tumor formation but higher tumor expression associates with poor patient outcome.

Chan SH, Yee Ko JM, Chan KW, Chan YP, Tao Q, Hyytiainen M, Keski-Oja J, Law S, Srivastava G, Tang J, Tsao SW, Chen H, Stanbridge EJ, Lung ML.

Int J Cancer. 2011 Aug 1;129(3):565-73. doi: 10.1002/ijc.25698. Epub 2010 Nov 9.


Epigenetic inactivation of secreted frizzled-related protein 2 in esophageal squamous cell carcinoma.

Hao XW, Zhu ST, He YL, Li P, Wang YJ, Zhang ST.

World J Gastroenterol. 2012 Feb 14;18(6):532-40. doi: 10.3748/wjg.v18.i6.532.


Identification of an invasion and tumor-suppressing gene, Endoglin (ENG), silenced by both epigenetic inactivation and allelic loss in esophageal squamous cell carcinoma.

Wong VC, Chan PL, Bernabeu C, Law S, Wang LD, Li JL, Tsao SW, Srivastava G, Lung ML.

Int J Cancer. 2008 Dec 15;123(12):2816-23. doi: 10.1002/ijc.23882.


Monochromosome transfer and microarray analysis identify a critical tumor-suppressive region mapping to chromosome 13q14 and THSD1 in esophageal carcinoma.

Ko JM, Chan PL, Yau WL, Chan HK, Chan KC, Yu ZY, Kwong FM, Miller LD, Liu ET, Yang LC, Lo PH, Stanbridge EJ, Tang JC, Srivastava G, Tsao SW, Law S, Lung ML.

Mol Cancer Res. 2008 Apr;6(4):592-603. doi: 10.1158/1541-7786.MCR-07-0154.


Rab25 is a tumor suppressor gene with antiangiogenic and anti-invasive activities in esophageal squamous cell carcinoma.

Tong M, Chan KW, Bao JY, Wong KY, Chen JN, Kwan PS, Tang KH, Fu L, Qin YR, Lok S, Guan XY, Ma S.

Cancer Res. 2012 Nov 15;72(22):6024-35. doi: 10.1158/0008-5472.CAN-12-1269. Epub 2012 Sep 18.


Characterization of a novel tumor-suppressor gene PLC delta 1 at 3p22 in esophageal squamous cell carcinoma.

Fu L, Qin YR, Xie D, Hu L, Kwong DL, Srivastava G, Tsao SW, Guan XY.

Cancer Res. 2007 Nov 15;67(22):10720-6. Erratum in: Cancer Res. 2008 May 1;68(9):3549.


Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinoma.

Ma S, Bao JY, Kwan PS, Chan YP, Tong CM, Fu L, Zhang N, Tong AH, Qin YR, Tsao SW, Chan KW, Lok S, Guan XY.

Gastroenterology. 2012 Sep;143(3):675-86.e1-12. doi: 10.1053/j.gastro.2012.06.007. Epub 2012 Jun 13.


Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.

Li Y, Fu L, Li JB, Qin Y, Zeng TT, Zhou J, Zeng ZL, Chen J, Cao TT, Ban X, Qian C, Cai Z, Xie D, Huang P, Guan XY.

Gastroenterology. 2014 Jun;146(7):1701-13.e9. doi: 10.1053/j.gastro.2014.02.029. Epub 2014 Feb 21.


LTBP-2 confers pleiotropic suppression and promotes dormancy in a growth factor permissive microenvironment in nasopharyngeal carcinoma.

Chen H, Ko JM, Wong VC, Hyytiainen M, Keski-Oja J, Chua D, Nicholls JM, Cheung FM, Lee AW, Kwong DL, Chiu PM, Zabarovsky ER, Tsao SW, Tao Q, Kan R, Chan SH, Stanbridge EJ, Lung ML.

Cancer Lett. 2012 Dec 1;325(1):89-98. doi: 10.1016/j.canlet.2012.06.005. Epub 2012 Jun 26.


TGF-β1 induces epigenetic silence of TIP30 to promote tumor metastasis in esophageal carcinoma.

Bu F, Liu X, Li J, Chen S, Tong X, Ma C, Mao H, Pan F, Li X, Chen B, Xu L, Li E, Kou G, Han J, Guo S, Zhao J, Guo Y.

Oncotarget. 2015 Feb 10;6(4):2120-33.


Increased levels of the long intergenic non-protein coding RNA POU3F3 promote DNA methylation in esophageal squamous cell carcinoma cells.

Li W, Zheng J, Deng J, You Y, Wu H, Li N, Lu J, Zhou Y.

Gastroenterology. 2014 Jun;146(7):1714-26.e5. doi: 10.1053/j.gastro.2014.03.002. Epub 2014 Mar 12.


Identification of GPX3 epigenetically silenced by CpG methylation in human esophageal squamous cell carcinoma.

He Y, Wang Y, Li P, Zhu S, Wang J, Zhang S.

Dig Dis Sci. 2011 Mar;56(3):681-8. doi: 10.1007/s10620-010-1369-0. Epub 2010 Aug 20.


Long non-coding RNA HOTAIR, a driver of malignancy, predicts negative prognosis and exhibits oncogenic activity in oesophageal squamous cell carcinoma.

Li X, Wu Z, Mei Q, Li X, Guo M, Fu X, Han W.

Br J Cancer. 2013 Oct 15;109(8):2266-78. doi: 10.1038/bjc.2013.548. Epub 2013 Sep 10.


Characterization of tumor-suppressive function of SOX6 in human esophageal squamous cell carcinoma.

Qin YR, Tang H, Xie F, Liu H, Zhu Y, Ai J, Chen L, Li Y, Kwong DL, Fu L, Guan XY.

Clin Cancer Res. 2011 Jan 1;17(1):46-55. doi: 10.1158/1078-0432.CCR-10-1155. Epub 2010 Nov 17.


Flotillin-1 promotes tumor necrosis factor-α receptor signaling and activation of NF-κB in esophageal squamous cell carcinoma cells.

Song L, Gong H, Lin C, Wang C, Liu L, Wu J, Li M, Li J.

Gastroenterology. 2012 Oct;143(4):995-1005.e12. doi: 10.1053/j.gastro.2012.06.033. Epub 2012 Jun 23.


Tumor suppressor dual-specificity phosphatase 6 (DUSP6) impairs cell invasion and epithelial-mesenchymal transition (EMT)-associated phenotype.

Wong VC, Chen H, Ko JM, Chan KW, Chan YP, Law S, Chua D, Kwong DL, Lung HL, Srivastava G, Tang JC, Tsao SW, Zabarovsky ER, Stanbridge EJ, Lung ML.

Int J Cancer. 2012 Jan 1;130(1):83-95. doi: 10.1002/ijc.25970. Epub 2011 Apr 20.


PTPLAD2 is a tumor suppressor in esophageal squamous cell carcinogenesis.

Zhu S, Wang Z, Zhang Z, Wang J, Li Y, Yao L, Mei Q, Zhang W.

FEBS Lett. 2014 Mar 18;588(6):981-9. doi: 10.1016/j.febslet.2014.01.058. Epub 2014 Feb 14.


Epigenetic inactivation of SPINT2 is associated with tumor suppressive function in esophageal squamous cell carcinoma.

Yue D, Fan Q, Chen X, Li F, Wang L, Huang L, Dong W, Chen X, Zhang Z, Liu J, Wang F, Wang M, Zhang B, Zhang Y.

Exp Cell Res. 2014 Mar 10;322(1):149-58. doi: 10.1016/j.yexcr.2013.11.009. Epub 2013 Nov 21.


CD47 expression regulated by the miR-133a tumor suppressor is a novel prognostic marker in esophageal squamous cell carcinoma.

Suzuki S, Yokobori T, Tanaka N, Sakai M, Sano A, Inose T, Sohda M, Nakajima M, Miyazaki T, Kato H, Kuwano H.

Oncol Rep. 2012 Aug;28(2):465-72. doi: 10.3892/or.2012.1831. Epub 2012 May 24.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk